Skip to content

EBIT at other companies

Merck & Co. logo
Merck & Co.MRK
Idexx Laboratories logo
Idexx LaboratoriesIDXX
Revvity logo
RevvityRVTY
Tractor Supply Company logo
Tractor Supply CompanyTSCO
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$33B-32.3%
Enterprise value$41.04B-26.4%
P/E12.5×-7.1×
P/S3.5×-1.8×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Calculated from Zoetis’s reported figures.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's EBIT?
Zoetis (ZTS) reported EBIT of $820M in Q1 2026.
How has Zoetis's EBIT changed year-over-year?
Zoetis's EBIT decreased by 0.8% year-over-year, from $827M to $820M.
What is the long-term trend for Zoetis's EBIT?
Over 4 years (2021 to 2025), Zoetis's EBIT has grown at a 6.9% compound annual growth rate (CAGR), from $2.71B to $3.55B.
What does EBIT mean?
Profit before interest and taxes — the business's core earning power.
How do you interpret EBIT?
Higher is better. Because it adds back interest, EBIT compares earning power across firms with very different debt loads — the base for interest coverage and the EV/EBIT multiple. For filers reporting operating income it equals that line, excluding non-operating swings.
How does EBIT compare across companies?
Comparable across companies regardless of leverage or tax domicile; the standard 'earning power' line for cross-company analysis. Least meaningful for banks and insurers.